Filter posts

How Industry Rates Interactions with the FDA

Kicking off day one of the BIO CEO & Investor Conference in New York City, …

SBIR Funds Speed the Delivery of Breakthrough Treatments and Cures

Today, BIO’s Executive Vice President of Emerging Companies Cartier Esham presented testimony to the U.S. …